• / Free eNewsletters & Magazine
  • / My Account
Home>Liquid Biopsy Markets 2017-2020: Focus on by Lung, Breast, Colorectal, Prostate and Others (Updated Report) - Research and Markets

Liquid Biopsy Markets 2017-2020: Focus on by Lung, Breast, Colorectal, Prostate and Others (Updated Report) - Research and Markets

Liquid Biopsy Markets 2017-2020: Focus on by Lung, Breast, Colorectal, Prostate and Others (Updated Report) - Research and Markets

09/29/2017

Liquid Biopsy Markets 2017-2020: Focus on by Lung, Breast, Colorectal, Prostate and Others (Updated Report) - Research and Markets

The "Liquid Biopsy Markets by Lung, Breast, Colorectal, Prostate and Other. 2017-2020 Including Screening Market Potential Size with Executive and Consultant Guides" report has been added to Research and Markets' offering.

The Diagnostic, Monitoring and Screening Test opportunities are explored

A revolution in cancer diagnostics is occurring using in vitro blood testing to identify cancer DNA. The technology creates new markets for cancer screening tests.

GRAIL, a new company with impressive backing, has announced a single blood test to detect all cancers. The technology is moving faster than the market. New technology that definitively identifies disease conditions from blood samples is poised to replace expensive invasive surgical biopsy procedures. The market is still in its infancy but has outstanding growth potential. The impact on the health care industry is enormous. The report forecasts the market size out to 2020. In addition, the report looks at potential market sizes by country, by cancer and by the three different opportunities: detection, management and screening.

Use independent research that makes you the expert. Get our research team working for you by ordering this comprehensive report. Your credit card order sends the report to your inbox instantly. Check all your licensing options but don't worry, your order is available as a credit if you wish to upgrade to more information. Get an extra player on your team as unlimited assistance and breakout data is included with your purchase.

Circulating Tumor Cells? Cell Free DNA? Exosomes? Find out about the technology in readily understood terms that explain the jargon. Find the opportunities and the pitfalls. Understand growth expectations and the ultimate potential market size.

The report includes detailed breakouts for 15 Countries and 4 Regions along with breakouts for Lung, Breast, Colorectal, Prostate and Other Cancers.

Key Topics Covered:

1. Introduction and Market Definition

2. Market Overview

3. Market Trends

4. Liquid Biopsy Recent Developments

5. Country Market Sizes - North America

6. Country Markets - Europe

7. Country Markets - Asia Pacific

8. Country Markets - Latin America, Africa & The Middle East

9. Global Market Summary

10. Potential Market Opportunity Sizes

Companies Mentioned

  • AccuraGen
  • AdnaGen
  • Agena Bioscience
  • Angle plc
  • AstraZeneca
  • Baylor
  • Biocept
  • Biodesix
  • BioFluidica
  • Bio-Rad Laboratories
  • Epic Sciences
  • Exosome Diagnostics
  • Fluidigm Corp
  • Fluxion Biosciences
  • For Liquid Biopsy
  • Freenome
  • iCellate
  • Illumina
  • Inivata
  • Janssen Diagnostics
  • Molecular MD
  • Myriad Genetics
  • Natera
  • New Oncology
  • Pathway Genomics
  • Resolution Bio
  • Roche
  • Rosetta Genomics
  • Silicon Biosystems
  • SRI International
  • Sysmex Inostics
  • TGen
  • Tokai
  • Trovagene
  • WaveSense

For more information about this report visit https://www.researchandmarkets.com/research/62xqqt/liquid_biopsy

About Research and Markets

Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: In Vitro Diagnostics

©2017 Morningstar Advisor. All right reserved.